Hydrocodone/acetaminophen and tramadol chlorhydrate combination tablets for the management of chronic cancer pain: A double-blind comparative trial

Clinical Journal of Pain

Volumn 24, Issue 1, 2008, Pages 1-4

  Rodriguez, Rene Fernando ^a   Castillo, Javier M ^a   Castillo, María P ^a   Montoya, Olga ^a   Daza, Paola ^a   Rodríguez, Mario F ^a   Restrepo, José M ^a   León, Miguel E ^a   Angel, Ana M ^a  

^a UNIVERSIDAD LIBRE   (Colombia)

Author keywords

Acetaminophen; Cancer pain; Hydrocodone; Opioid; Palliative care; Tramadol

Indexed keywords

BISACODYL; HYDROCODONE; OPIATE; PARACETAMOL; TRAMADOL;

ADULT; AGED; ANALGESIA; ANOREXIA; ARTICLE; BEDTIME DOSAGE; BREAST CANCER; CANCER PAIN; CANCER PALLIATIVE THERAPY; CHRONIC PAIN; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SIDE EFFECT; STOMACH CANCER; TABLET; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VOMITING; WEAKNESS; XEROSTOMIA;

ACETAMINOPHEN; AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCODONE; MALE; MIDDLE AGED; NEOPLASMS; PAIN MEASUREMENT; PAIN, INTRACTABLE; TABLETS; TRAMADOL; TREATMENT OUTCOME;

EID: 38049023693     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318156ca4d     Document Type: Article

References (27)

1. WHO. Cancer Pain Relief. Geneva: World Health Organisation. 1996:3-37.
2. Brooks D, Gamble W, Ahmedzai S. A regional survey of opioid use by patients receiving specialist palliative care. Palliat Med. 1995;3:229-238.
3. White I, Hoskin P, Hanks G, et al. Morphine and dryness of the mouth. Br Med J. 1989;298:1222-1223.
4. Ripamontic C, Duke ED. Strategies for the treatment of cancer pain in the new millennium. Drugs. 2001;61:955-977.
5. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastasic cancer. N Engl J Med. 1994;330:592-596.
6. Larue F, Colleau SM, Brasseur L, et al. Multicenter study of cancer pain and its treatment in France. BMJ. 1995;310:1034-1037.
7. Jadad A, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. J Am Med Assoc. 1995;274:1870-1873.
8. Mullican SW, Lacy JR. Tramadol/acetaminophen combination tablets and Codeine/acetaminophen Capsules for the management of chronic pain: a comparative trial. Clin Ther. 2001;9:1429-1444.
9. Hanks GW, de Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587-593.
10. Meresaar U, Nilson MI, Holmstrand J, et al. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Eur J Clin Pharmacol. 1981;20:473-478.
11. Fainsinger R, Schoeller T, Bruera E. Methadone in the management of cancer pain: a review. Pain. 1993;52:137-147.
12. Twycross R, Bergh S, John S, et al. Monitoring drug use in palliative care. Palliat Med. 1994;8:137-143.
13. Payne R, Thomas J, Raj P. Dolor debido al cancer. epidemiología y enfoque terapéutico. In: Raj PP, ed. Tratamiento Práctico del Dolor. Madrid: Mosby Yearbook; 1994:428-444.
14. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995;332:1685.
15. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg. 1993;76:182.
16. Stein C, Yassouridis A. Peripheral morphine analgesia. Pain. 1997;71:119-121.
17. Miralles FP, González JM, Vaca JM. Investigación en el dolor experimental, medición y valoración del dolor. In: Torres LM, ed. Medicina del Dolor. Barcelona: Editorial Masson SA; 1997:19-33.
18. Murillo EC. Calidad de vida del enfermo neoplásico. In: González MB, ed. Tratado de Medicina Paliativa y Tratamiento de Soporte en el Enfermo con Cáncer. Madrid: Panamericana; 1996:75-76.
19. Rodríguez RF. Manejo farmacológico del dolor en pacientes con cáncer. In: Rodríguez RF, ed. Medicina del Dolor y Cuidados Paliativos. Cali: Edit. Universidad Libre de Cali; 1998:173-182.
20. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy. 1999;24:115-123.
21. Schnitzer TJ, Gray WL, Paster RZ, et al. Efficacy of tramadol in treatment of chronic pain. J Rheumatol. 2000;6:250-257.
22. Fricke JR, Karim R, Jordan D, et al. A double blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets and placebo after oral surgery. Clin Ther. 2002;24:953-968.
23. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs. 2003;63:17-32.
24. Przewlocki R, Przewlocka B. Opioids in chronic pain. Eur J Pharmacol. 2001;429:79-91.
25. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy. 1999;19:88-93.
26. Rauck RL, Ruoff GE, McMillen JI. Comparison of tramadol and acetaminophen with codeine for long term pain management in elderly patients. Curr Ther Res. 1994;55:1417-1431.
27. Fillingim RB, Ness TJ, Glover TL, et al. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J Pain. 2005;6:116-124.